Usefulness of MoCA in detecting preclinical AD
MoCA total, the common dementia screening test also plays a valuable role in detecting preclinical AD.
Authors
- Val J. Lowe (ORCID: https://orcid.org/0000-0002-5612-1667)
- Dana Tudorascu (ORCID: https://orcid.org/0000-0003-4675-3692)
- Tharick Ali Pascoal (ORCID: https://orcid.org/0000-0001-9057-8014)
- Ziad Nasreddine
- Belén Pascual (ORCID: https://orcid.org/0000-0002-4467-7406)
- Joseph C. Masdeu (ORCID: https://orcid.org/0000-0001-9955-6954)
- Beth E. Snitz (ORCID: https://orcid.org/0000-0002-9978-1374)
- Suzanne L. Baker (ORCID: https://orcid.org/0000-0003-0209-3127)
- Firoza Zubeida Lussier (ORCID: https://orcid.org/0000-0002-6877-4825)
- David Soleimani‐Meigooni
- Pampa Saha (ORCID: https://orcid.org/0000-0002-4926-9081)
- Juan M. Fortea (ORCID: https://orcid.org/0000-0002-1340-638X)
- Hwamee Oh (ORCID: https://orcid.org/0000-0003-1156-5704)
- Felix Joy Kollasserry
- Pamela C.L. Ferreira
- Livia Amaral
- Guilherme Povala
- George Rebok
- Brian A. Gordon
- Pedro Rosa‐Neto
- Cynthia Felix
Institutions
- Houston Methodist (US)
- Johns Hopkins University (US)
- Lawrence Berkeley National Laboratory (US)
- University of Pittsburgh (US)
- University of California, San Francisco (US)
- Washington University in St. Louis (US)
- Brown University (US)
- Hospital de Sant Pau (ES)
- University Memory and Aging Center (US)
- Alzheimer’s Disease Neuroimaging Initiative (US)
- Mayo Clinic in Arizona (US)
- McGill University (CA)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70857_105912
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00